Different Impact of Immunosuppressive Therapy on Cardiac Outcomes in Systemic Versus Isolated Cardiac Sarcoidosis-Reference-Cited by-同舟云学术

Different Impact of Immunosuppressive Therapy on Cardiac Outcomes in Systemic Versus Isolated Cardiac Sarcoidosis

Published:2024 Issue: Volume: Page:
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Masunaga Tomoka¹²,Hashimoto Toru¹²,Fujino Takeo¹³,Ohtani Kisho⁴,Ishikawa Yusuke¹,Yoshitake Tomoaki¹²,Shinohara Keisuke¹,Matsushima Shouji¹²,Ide Tomomi¹²,Yamasaki Yuzo⁵,Isoda Takuro⁵,Baba Shingo⁵⁶,Ishigami Kousei⁵,Tsutsui Hiroyuki¹²⁷,Kinugawa Shintaro¹²

Affiliation:

1. Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University

2. Division of Cardiovascular Medicine, Research Institute of Angiocardiology, Faculty of Medical Sciences, Kyushu University

3. Department of Advanced Cardiopulmonary Failure, Faculty of Medical Sciences, Kyushu University

4. Department of Cardiovascular Medicine, National Hospital Organization Kyushu Medical Center

5. Department of Clinical Radiology, Faculty of Medical Sciences, Kyushu University

6. Department of Health Sciences, Graduate School of Medical Sciences, Kyushu University

7. School of Medicine and Graduate School, International University of Health and Welfare

Publisher

International Heart Journal (Japanese Heart Journal)

Link

https://www.jstage.jst.go.jp/article/ihj/advpub/0/advpub_24-166/_pdf

Reference31 articles.

1. 1. Terasaki F, Azuma A, Anzai T, et al. JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis - Digest Version. Circ J 2019; 83: 2329-88.

2. 2. Kim JS, Judson MA, Donnino R, et al. Cardiac sarcoidosis. Am Heart J 2009; 157: 9-21.

3. 3. Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014; 11: 1305-23.

4. 4. Hiraga H, Iwai K. Guidelines for diagnosis of cardiac sarcoidosis: study report on diffuse pulmonary disease (Japanese). The Japanese Ministry of Health and Welfare 1993.

5. 5. Nabeta T, Kitai T, Naruse Y, et al. Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry. Eur Heart J 2022; 43: 3450-9.